asklepios course - esor.org€¦ · • to understand the basic principle of mri technique ......

myE

SR.o

rg/e

sor

Education in partnership

ASKLEPIOS Course

NEURORADIOLOGYJuly 20–21, 2018 Bangkok/Thailand

This ASKLEPIOS course is implemented with great support and partnership of Guerbet and RCRT (Royal College of Radiologists of Thailand).

myE

SR.o

rg/e

sor

ASK

LEP

IOS

Co

urse

N

EU

RO

RA

DIO

LOG

Y

ASKLEPIOS CourseNEURORADIOLOGYJuly 20–21, 2018 Bangkok/Thailand

Course information

This ESOR course aims to discuss the most important topics in neuroradiology. Experienced neuroradiologists will give an update on Computed tomography (CT) and magnetic resonance imaging (MRI) techniques and introduce imaging algorithms for vascular, infectious, inflammatory and demyelinating diseases of the central nervous system (CNS).

Learning objectives

• to introduce the practical approach to image and understand traumatic brain injury

• to learn how to use conventional and advanced techniques in evaluation of infectious and inflammatory brain disorders

• to review classification and give an update on multiple sclerosis

• to discuss current treatment strategies in stroke

myE

SR.o

rg/e

sor

ASK

LEP

IOS

Co

urse

N

EU

RO

RA

DIO

LOG

Y

For further information on the programme and registration please visit

Friday, July 20, 2018

08:00–08:45 Registration

08:45–09:00 Welcome and introduction

09:00–09:30 Neuroimaging in patients with traumatic brain injury: a practical guide

P.M. Parizel, Antwerp/BE

09:30–10:00 CNS infections: A roadmap from imaging to pathogen M. Thurnher, Vienna/AT

10:00–10:30 Venous ischemia, pathophysiology and diagnosis P. Vilela, Lisbon/PT

10:30–10:50 Coffee break

10:50–13:00 Workshops (P.M. Parizel, M. Thurnher, P. Vilela)

13:00–14:00 Lunch break

14:00–14:30 Presurgical and postoperative evaluation of brain tumours P.M. Parizel, Antwerp/BE

14:30–15:00 Emerging inflammatory and autoimmune CNS diseases M. Thurnher, Vienna/AT

15:00–15:30 Multiple Sclerosis: where do we stand? J.-P. Pruvo, Lille/FR


15:50–18:00 Workshops (P.M. Parizel, M. Thurnher, J.-P. Pruvo)

Saturday, July 21, 2018

09:00–09:30 Recanalization and reperfusion in acute cerebral ischemia: controlled studies and guidelines

P. Vilela, Lisbon/PT

09:30–10:00 Adjunct value of vessel wall imaging in clinical practice: experience at Siriraj Hospital

O. Chawalparit, Bangkok/TH

10:00–10:30 Thrombectomy in stroke J.-P. Pruvo, Lille/FR


10:50–13:00 Workshops (P. Vilela, O. Chawalparit, J.-P. Pruvo)

13:00 Certificate of attendance

ProgrammeNEURORADIOLOGY

July 20–21, 2018 Bangkok/Thailand

Host Organiser

A. ChurojanaBangkok/TH

VenueAnantara Riverside Bangkok Resort

257/1-3 Charoennakorn Road, Thonburi 10600 Bangkok

Thailand

Registration informationFor information about the registration,

please visit myESR.org/esor


http://myESR.org/esor

myE

SR.o

rg/e

sor

ASK

LEP

IOS

Co

urse

N

EU

RO

RA

DIO

LOG

Y

NEURORADIOLOGYJuly 20–21, 2018 Bangkok/Thailand

Learning Objectives

Neuroimaging in patients with traumatic brain injury: a practical guideP.M. Parizel, Antwerp/BE

• to present a pattern-based diagnostic approach to the patient with acute traumatic brain injury

• to review different types of traumatic intracranial lesions, and explain the difference between primary and secondary traumatic brain lesions

• to illustrate how the brain can be severely damaged in closed head injuries (deceleration trauma, diffuse axonal injuries)

• to demonstrate how advanced MRI techniques, such as DWI and DTI, can reveal evidence for micro-structural brain damage

CNS infections: A roadmap from imaging to pathogenM. Thurnher, Vienna/AT

• to learn how to distinguish infectious from neoplastic ring-like enhancing brain lesions

• to discuss the role of different MRI techniques in differentiation of bacterial, fungal and parasitic infections

• to introduce a roadmap for evaluation of infectious brain masses

Venous ischemia, pathophysiology and diagnosisP. Vilela, Lisbon/PT

• to review the most common aetiologies and clinical presentation of brain and spine venous ischemia

• to understand the pathophysiologic mechanisms of venous ischemia

• to review the imaging CT and MRI findings of venous thrombosis and ischemia

• to become familiar with the strategies for venous thrombosis and brain malformations treatment

Presurgical and postoperative evaluation of brain tumoursP.M. Parizel, Antwerp/BE

• to review the presurgical imaging criteria for the detection and characterisation of intra- and extra-axial brain tumours

• to learn about the application of MR techniques including DWI, PWI, MRS for better delineation and characterisation of brain tumours

• to understand the crucial role of neuroimaging in the posttreatment glioma patient to differentiate normal post-operative findings from progression or pseudoprogression


myE

SR.o

rg/e

sor

ASK

LEP

IOS

Co

urse

N

EU

RO

RA

DIO

LOG

Y

Learning ObjectivesNEURORADIOLOGY

July 20–21, 2018 Bangkok/Thailand

Emerging inflammatory and autoimmune CNS diseasesM. Thurnher, Vienna/AT

• to learn about newly recognised classes of autoimmune encephalitides

• to review MR imaging findings suggestive of CNS involvement in autoimmune inflammatory diseases

• to understand the mechanism of antibody-mediated disorders of the nervous system

Multiple Sclerosis: where do we stand?J.-P. Pruvo, Lille/FR

Recanalization and reperfusion in acute cerebral ischemia: controlled studies and guidelinesP. Vilela, Lisbon/PT

• to review the most common aetiologies, pathophysiologic mechanisms, imaging findings and to understand the importance of multimodal CT and/or MR imaging protocols for patient selection in acute ischemic stroke

• to review the most recent studies on endovascular treatment of acute ischemic stroke treatment

• to become familiar with the most recent published guidelines for acute ischemic stroke treatment

• to become familiar with the interventional (endovascular) techniques used for the treatment of acute ischemic stroke

• to analyse some debatable issues of acute ischemic stroke: type of anaesthesia, distal occlusions treatment, acute phase arterial stenting

Adjunct value of vessel wall imaging in clinical practice: experience at Siriraj HospitalO. Chawalparit, Bangkok/TH

• to understand the basic principle of MRI technique for vessel wall imaging

• to realise the Adjunct value of the VWI in stroke and common vascular disease

• to be aware of pitfall in interpreting the VWI

• to be able to give suggestion to the clinician for proper technique selection and patient management

Thrombectomy in strokeJ.-P. Pruvo, Lille/FR


myE

SR.o

rg/e

sor

ASK

LEP

IOS

Co

urse

N

EU

RO

RA

DIO

LOG

Y

For further information on the programme and registration please visit

P17

234

DOT

- No

vem

ber 2

017

- Im

ager

y : G

uerb

et, S

hutte

rsto

ckan

napu

rna8

000

Stability is in its DNAUpon the conception of Dotarem®, Guerbet’s research team, in order to minimize the release risk of gadolinium, designed the gadoterate meglumine molecule to provide high chemical stability. 1 Dotarem® shows a unique profile based on its original features:• Macrocyclic & ionic molecule developed by Guerbet’s researchers• Patented manufacturing process•

unconfounded cases of NSF 2-4

• No visible brain hyperintensities, even in cases of repeated injections 5-8

COMMITTED

1. Meyer D et al. Gd-DOTA, a potential MRI contrast agent. Current status of physicochemical knowledge. Invest Radiol. 1988 Sep;23 Suppl 1:S232-5. 2. Internal data as of November 2017. 3. Dotarem® USA PI as of November 2017. 4. de Kerviler E et al. Adverse reactions to gadoterate meglumine: review of over 25 years of clinical use and more than 50 million doses. Invest Radiol. 2016 Sep;51(9):544-51. 5. Radbruch A et al. Gadolinium retention in the dentate nucleus and globus pallidus is dependent on the class of contrast agent. Radiology. 2015 Jun;275(3):783-91. 6. Eisele P et al. Lack of increased signal intensity in the dentate nucleus after repeated administration of a macrocyclic contrast agent in multiple sclerosis: An observational study. Medicine (Baltimore). 2016 Sep;95(39):e4624. 7. Radbruch A et al. No signal intensity increase in the dentate nucleus on unenhanced T1-weighted MR images after more than 20 serial injections of macrocyclic gadolinium-based contrast agents. Radiology. 2017 Mar;282(3):699-707. 8. Radbruch A et al. Pediatric brain: no increased signal intensity in the dentate nucleus on unenhanced T1-weighted MR images after consecutive exposure to a macrocyclic gadolinium-based contrast agent. Radiology. 2017 Jun;283(3):828-36.

P17

234

DOT

- No

vem

ber 2

017

- Im

ager

y : G

uerb

et, S

hutte

rsto

ckan

napu

rna8

000

Stability is in its DNAUpon the conception of Dotarem®, Guerbet’s research team, in order to minimize the release risk of gadolinium, designed the gadoterate meglumine molecule to provide high chemical stability. 1 Dotarem® shows a unique profile based on its original features:• Macrocyclic & ionic molecule developed by Guerbet’s researchers• Patented manufacturing process•

unconfounded cases of NSF 2-4

• No visible brain hyperintensities, even in cases of repeated injections 5-8

COMMITTED

1. Meyer D et al. Gd-DOTA, a potential MRI contrast agent. Current status of physicochemical knowledge. Invest Radiol. 1988 Sep;23 Suppl 1:S232-5. 2. Internal data as of November 2017. 3. Dotarem® USA PI as of November 2017. 4. de Kerviler E et al. Adverse reactions to gadoterate meglumine: review of over 25 years of clinical use and more than 50 million doses. Invest Radiol. 2016 Sep;51(9):544-51. 5. Radbruch A et al. Gadolinium retention in the dentate nucleus and globus pallidus is dependent on the class of contrast agent. Radiology. 2015 Jun;275(3):783-91. 6. Eisele P et al. Lack of increased signal intensity in the dentate nucleus after repeated administration of a macrocyclic contrast agent in multiple sclerosis: An observational study. Medicine (Baltimore). 2016 Sep;95(39):e4624. 7. Radbruch A et al. No signal intensity increase in the dentate nucleus on unenhanced T1-weighted MR images after more than 20 serial injections of macrocyclic gadolinium-based contrast agents. Radiology. 2017 Mar;282(3):699-707. 8. Radbruch A et al. Pediatric brain: no increased signal intensity in the dentate nucleus on unenhanced T1-weighted MR images after consecutive exposure to a macrocyclic gadolinium-based contrast agent. Radiology. 2017 Jun;283(3):828-36.

myE

SR.o

rg/e

sor

Please note that programmes are marked with a logo to indicate their classification according to the European Training Curriculum.

First three years of training

Fourth and fifth year of training (general radiologist standard)

Subspecialty training standard

ESOR stands for education in partnership.


asklepios course - esor.org€¦ · • to understand the basic principle of mri technique ......

Documents